Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Oscar Health (NYSE:OSCR) and raises the price target from $24 to $27.
June 12, 2024 | 10:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Oscar Health and raises the price target from $24 to $27.
The raised price target and maintained Overweight rating from a reputable analyst at Wells Fargo is likely to positively impact investor sentiment and drive short-term price appreciation for Oscar Health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100